SCHEMBL4067700

SCHEMBL4067700

Cc1cc(Cl)ccc1Oc1ccc(NC(=O)c2ccccc2Cl)c(C)n1

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.50
RAB9A P51151 3/20 0.49
PNLIP P16233 2/20 0.48
TP53 P04637 1/20 0.48
KDM4E B2RXH2 2/20 0.48
MAPT P10636 2/20 0.48
LMNA P02545 1/20 0.48
SMN1; SMN2 Q16637 3/20 0.47
NPC1 O15118 2/20 0.47
KMT2A Q03164 3/20 0.47
MEN1 O00255 2/20 0.47
GRM4 Q14833 2/20 0.46
HDAC1 Q13547 1/20 0.45
HDAC8 Q9BY41 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
KCNMA1 Q12791 1/20 0.45
POLB P06746 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4061920 0.93 ALDH1A1 (0.60) ALDH1A1RAB9APNLIPKDM4EMAPT
SCHEMBL4064583 0.91 ALDH1A1 (0.49) ALDH1A1RAB9APNLIPTP53KDM4E
SCHEMBL4070607 0.88 RAB9A (0.41) ALDH1A1RAB9ATP53KDM4EMAPT
SCHEMBL4065194 0.83 ALDH1A1 (0.58) ALDH1A1RAB9APNLIPKDM4EMAPT
SCHEMBL4065181 0.81 GRM4 (0.57) PNLIPTP53KMT2AMEN1GRM4
SCHEMBL4072610 0.79 TYK2 (0.42) ALDH1A1RAB9ATP53MAPTSMN1; SMN2
SCHEMBL4071750 0.75 PNLIP (0.55) PNLIPTP53GRM4
SCHEMBL4069795 0.75 ALDH1A1 (0.43) ALDH1A1TP53KDM4EMAPTSMN1; SMN2
SCHEMBL4062244 0.73 PNLIP (0.60) ALDH1A1RAB9APNLIPMAPTNPC1
SCHEMBL4060818 0.72 HTR2C (0.52) ALDH1A1RAB9APNLIPTP53KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1028945-B9 SUBSTITUTED PYRIDINE COMPOUNDS AS ANTI-INFLAMMATORY AGENTS AMGEN INC (US) 2009-02-18 EP disclosed
EP-1028945-B1 SUBSTITUTED PYRIDINE COMPOUNDS AS ANTI-INFLAMMATORY AGENTS AMGEN INC (US) 2007-07-11 EP disclosed